BPC2001 / BioPhoenix - LARVOL DELTA

BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation (clinicaltrials.gov) - P2 | N=50 | Recruiting | Sponsor: BioPhoenix Co., Ltd. | Trial completion date: Feb 2028 ➔ Dec 2028 | Trial primary completion date: Nov 2027 ➔ Apr 2028

Trial completion date • Trial primary completion date • Acute Graft versus Host Disease • Acute Lymphocytic Leukemia • Chronic Graft versus Host Disease • Graft versus Host Disease • Hematological Malignancies • Immunology • Myelodysplastic Syndrome • Transplantation

BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation (clinicaltrials.gov) - P2 | N=50 | Recruiting | Sponsor: BioPhoenix Co., Ltd.

New P2 trial • Acute Graft versus Host Disease • Chronic Graft versus Host Disease • Graft versus Host Disease • Immunology • Transplantation